| GSE86982 | GSM2317516 | Illumina HiSeq 2500 | Homo sapiens | 54Dn4_C04_smart-seq | cultured embryonic stem cells[DCX-][BG121099] | days in culture: 54; cre line: DCX-; differentiation#: BG121099; control: FALSE |
| GSE86982 | GSM2317772 | Illumina HiSeq 2500 | Homo sapiens | 26Dp3_C05_smart-seq | cultured embryonic stem cells[DCX+][RM165049] | days in culture: 26; cre line: DCX+; differentiation#: RM165049; control: FALSE |
| GSE86982 | GSM2318028 | Illumina HiSeq 2500 | Homo sapiens | 54Dn5_C03_smart-seq | cultured embryonic stem cells[DCX-][RM165048] | days in culture: 54; cre line: DCX-; differentiation#: RM165048; control: FALSE |
| GSE86982 | GSM2318284 | Illumina HiSeq 2500 | Homo sapiens | SK_3_A04_smart-seq | cultured embryonic stem cells[RM165095][viral_barcoded] | days in culture: 54; differentiation#: RM165095; control: FALSE; viral barcoded: viral_barcoded |
| GSE38495 | GSM967520 | Illumina Genome Analyzer IIx | Homo sapiens | LNCaP s8_HCT20634-Lncap-15 | LNCaP cell | cell line: LNCaP |
| GSE51254 | GSM1241150 | Illumina HiSeq 2000 | Homo sapiens | Single Cell Ovation-Nextera 4 | colon carcinoma HCT116 | cdna synthesis method: NuGEN Ovation; library construction method: Nextera (transposon); cell line: HCT116 |
| GSE52529 | GSM1269087 | Illumina HiSeq 2500 | Homo sapiens | Cell T24_CT_C08 | Human Skeletal Muscle Myoblasts (HSMM) | cell type: Human Skeletal Muscle Myoblasts (HSMM); hour post serum-switch: 24; debris: FALSE; control well: FALSE; cells in well: 1; library protocol: Single-cell |
| GSE57872 | GSM1395472 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH26_G02 | glioblastoma [None] | patient id: MGH26; cell type: Glioblastoma; subtype: None |
| GSE64016 | GSM1562568 | Illumina HiSeq 2500 | Homo sapiens | H1_Exp3.260 | single H1 hESC | cell type: human embryonic stem cells; passages: 30-35; treatment: not sorted |
| GSE64016 | GSM1562833 | Illumina HiSeq 2500 | Homo sapiens | G2_Exp1.055 | single H1-Fucci cell sorted from G2-M phase of the cell cycle only | cell type: human embryonic stem cells; passages: 35-40; treatment: FACS sorted |
